InnoCare Pharma Limited (HKG:9969)
Hong Kong
· Delayed Price · Currency is HKD 19.60
+1.19 (6.46%)
Aug 15, 2025, 4:08 PM HKT
InnoCare Pharma Market Cap
InnoCare Pharma has a market cap or net worth of 38.49 billion as of August 15, 2025. Its market cap has increased by 315.83% in one year.
Market Cap
38.49B
Enterprise Value
32.65B
Revenue
1.31B
Ranking
n/a
PE Ratio
n/a
Stock Price
19.60
Market Cap Chart
Since March 23, 2020, InnoCare Pharma's market cap has increased from 12.28B to 38.49B, an increase of 213.47%. That is a compound annual growth rate of 23.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 38.49B | 204.66% |
| Dec 31, 2024 | 12.63B | -7.63% |
| Dec 29, 2023 | 13.68B | -44.57% |
| Dec 30, 2022 | 24.68B | 7.55% |
| Dec 31, 2021 | 22.95B | 32.04% |
| Dec 31, 2020 | 17.38B | 41.53% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 265.60B |
| Hansoh Pharmaceutical Group Company | 226.30B |
| JD Health International | 179.05B |
| Innovent Biologics | 162.71B |
| Akeso | 147.38B |
| Sino Biopharmaceutical | 137.89B |
| WuXi Biologics | 125.45B |
| CSPC Pharmaceutical Group | 119.48B |